4.8 Article

Label-free microfluidic paper-based electrochemical aptasensor for ultrasensitive and simultaneous multiplexed detection of cancer biomarkers

期刊

BIOSENSORS & BIOELECTRONICS
卷 136, 期 -, 页码 84-90

出版社

ELSEVIER ADVANCED TECHNOLOGY
DOI: 10.1016/j.bios.2019.04.032

关键词

Electrochemical aptasensor; Microfluidic paper-based device; Nanocomposites; Multiplexed detection; Cancer biomarkers

资金

  1. Key Research Programs of Frontier Sciences, CAS, China [QYZDJ-SSW-SYS015]
  2. National Key Research and Development Program, China [2017YFA0205902]
  3. NSFC, China [61527815, 61771452, 61775216]

向作者/读者索取更多资源

Simultaneous detection of multiple tumor biomarkers in body fluids could facilitate early diagnosis of lung cancer, so as to provide scientific reference for clinical treatment. This paper depicted a multi-parameter paper based electrochemical aptasensor for simultaneous detection of carcinoembryonic antigen (CEA) and neuron specific enolase (NSE) in a clinical sample with high sensitivity and specificity. The paper-based device was fabricated through wax printing and screen-printing, which enabled functions of sample filtration and sample auto injection. Amino functional graphene (NG)-Thionin (THI)-gold nanoparticles (AuNPs) and Prussian blue (PB)-poly (3,4-ethylenedioxythiophene) (PEDOT)-AuNPs nanocomposites were synthesized respectively. They were used to modify the working electrodes not only for promoting the electron transfer rate, but also for immobilization of the CEA and NSE aptamers. A label-free electrochemical method was adopted, enabling a rapid simple point-of-care testing. Experimental results showed that the proposed multi-parameter aptasensor exhibited good linearity in ranges of 0.01-500 ng mL(-1) for CEA (R-2 = 0.989) and 0.05-500 ng mL(-1) for NSE (R-2 = 0.944), respectively. The limit of detection (LOD) was 2 pg mL(-1) for CEA and 10 pg mL(-1) for NSE. In addition, the device was evaluated using clinical serum samples and received a good correlation with large electrochemical luminescence (ECL) equipment, which would offer a new platform for early cancer diagnostics, especially in those resource-limit areas.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据